Leggett & Platt Merger with Somnigroup Clears HSR Antitrust Review
LEG sits 24% above its 52-week low of $7.86.
Summary
Leggett & Platt announced that the Hart-Scott-Rodino antitrust waiting period for its acquisition by Somnigroup International has expired, moving the merger closer to completion.
Key Events · M&A and Partnerships · LEG
-
HSR Waiting Period Expired
The 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act for the acquisition by Somnigroup International expired on June 3, 2026.
-
Merger Progress Confirmed
This marks a significant regulatory milestone, bringing the all-stock transaction closer to its expected year-end 2026 closing.
-
Remaining Conditions
The merger remains subject to shareholder approval, additional international regulatory clearances, S-4 registration effectiveness, and absence of a material adverse effect.
Analysis · LEG · Manufacturing
This 8-K confirms a critical step in the acquisition of Leggett & Platt by Somnigroup International. The expiration of the HSR waiting period removes a major antitrust hurdle, reducing regulatory risk and increasing the likelihood of the merger closing as planned by year-end 2026. While other conditions, such as shareholder approval and international clearances, still need to be met, this development provides greater certainty for investors regarding the transaction's completion.
At the time of this filing, LEG was trading at $9.75 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $7.86 to $13.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.